Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.1B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.04B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.02B |
| 4 |
iShares China Large-Cap ETF
FXI
|
+$255M |
| 5 |
ARK Innovation ETF
ARKK
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$430M |
| 2 |
Microsoft
MSFT
|
+$365M |
| 3 |
Intel
INTC
|
+$335M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$333M |
| 5 |
Mercado Libre
MELI
|
+$309M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.43% |
| 2 | Healthcare | 5.69% |
| 3 | Financials | 4.7% |
| 4 | Consumer Discretionary | 4.61% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Hexcel
HXL
$7.97B
| $6.11M | ﹤0.01% |
89,592
-10,437
| -10% | -$708K |
|
1377
PTC Therapeutics
PTCT
$6.18B
| $6.11M | ﹤0.01% |
126,145
+25,797
| +26% | +$1.18M |
|
1378
CALL
Ross Stores
ROST
$80.8B
| $6.1M | ﹤0.01% |
57,500
+49,500
| +619% | +$5.56M |
|
1379
CALL
Union Pacific
UNP
$174B
| $6.1M | ﹤0.01% |
30,300
-60,000
| -66% | -$12.2M |
|
1380
CALL
Cameco
CCJ
$36.8B
| $6.1M | ﹤0.01% |
233,100
-116,900
| -33% | -$3.09M |
|
1381
Flowers Foods
FLO
$1.58B
| $6.09M | ﹤0.01% |
222,343
-624,281
| -74% | -$17.2M |
|
1382
Roku
ROKU
$21.6B
| $6.09M | ﹤0.01% |
92,574
-69,661
| -43% | -$4.08M |
|
|
KRTX
1383
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $6.07M | ﹤0.01% |
33,408
+13,750
| +70% | +$2.63M |
|
1384
Kymera Therapeutics
KYMR
$8.66B
| $6.07M | ﹤0.01% |
204,731
+72,647
| +55% | +$2.34M |
|
1385
Rhythm Pharmaceuticals
RYTM
$7.31B
| $6.06M | ﹤0.01% |
339,955
+64,394
| +23% | +$1.62M |
|
1386
Dynatrace
DT
$12.7B
| $6.03M | ﹤0.01% |
142,645
+26,600
| +23% | +$1.08M |
|
1387
CALL
American International
AIG
$42.5B
| $6.02M | ﹤0.01% |
119,600
-38,400
| -24% | -$2.24M |
|
|
CLCO
1388
DELISTED
Cool Company
CLCO
| $6.02M | ﹤0.01% |
+495,449
| New | +$6.06M |
|
1389
Omega Healthcare
OHI
$15.3B
| $6.01M | ﹤0.01% |
219,300
+110,013
| +101% | +$3.06M |
|
1390
Charles River Laboratories
CRL
$11.3B
| $6M | ﹤0.01% |
29,720
+10,830
| +57% | +$2.45M |
|
1391
Coherus Oncology
CHRS
$217M
| $5.95M | ﹤0.01% |
869,313
+102,229
| +13% | +$793K |
|
|
LNW
1392
DELISTED
Light & Wonder
LNW
| $5.95M | ﹤0.01% |
99,003
-4,801
| -5% | -$296K |
|
1393
NovoCure
NVCR
$1.76B
| $5.94M | ﹤0.01% |
98,835
-4,167
| -4% | -$333K |
|
1394
Fomento Económico Mexicano
FMX
$41.2B
| $5.94M | ﹤0.01% |
62,415
-27,792
| -31% | -$2.43M |
|
1395
Axalta
AXTA
$7.45B
| $5.93M | ﹤0.01% |
195,812
+77,869
| +66% | +$2.24M |
|
|
DOCU
1396
CALL
DocuSign
DOCU
$11.1B
| $5.92M | ﹤0.01% |
101,500
-137,900
| -58% | -$8.23M |
|
1397
Arrowhead Research
ARWR
$12.1B
| $5.92M | ﹤0.01% |
232,908
+95,568
| +70% | +$3.01M |
|
1398
CALL
RTX Corp
RTX
$290B
| $5.91M | ﹤0.01% |
+60,400
| New | +$5.95M |
|
|
MRTX
1399
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $5.91M | ﹤0.01% |
158,993
+36,279
| +30% | +$1.63M |
|
|
RETA
1400
CALL
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $5.91M | ﹤0.01% |
+65,000
| New | +$3.81M |
|
Similar funds
Citigroup's Q1 2023 Portfolio in Review
As of Q1 2023, Citigroup held 6,117 positions worth $143B, up 14% from $126B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Citigroup deployed $6.55B of net new capital in Q1 2023, opening 347 new positions and adding to 2,011 existing holdings. Its largest new stake was Direxion Daily S&P 500 Bull 2X ETF: 350,003 shares worth $28M.
By sector, the portfolio is most concentrated in Technology at 9.4% of assets, down from 9.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street Consumer Staples Select Sector SPDR ETF, an estimated $430M trimmed.
- Citigroup's largest Q1 2023 buy was Direxion Daily S&P 500 Bull 2X ETF: 350,003 shares worth $28M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $1.1B increase.
- Citigroup's biggest Q1 2023 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $430M.
- Citigroup fully exited LHC Group LLC in Q1 2023, selling an estimated $28.8M.
- Citigroup's ten largest holdings make up 34% of its $143B portfolio in Q1 2023.
- Citigroup opened 347 new positions and closed 668 in Q1 2023.
- Citigroup's portfolio value rose 14% quarter-over-quarter to $143B.
Based on Citigroup's 13F filing for Q1 2023, filed 11 May 2023.